Tournament: Byram Hills | Round: 2 | Opponent: Sam Hadiono | Judge: Tracy Brown
The status quo is rolling, innovation at a high
Daniel Cohen, Laura Furstenthal, and Leigh Jansen(et al) 20
https://www.mckinsey.com/industries/pharmaceuticals-and-medical-products/our-insights/healthcare-innovation-building-on-gains-made-through-the-crisis#
While the COVID-19 pandemic has placed unparalleled demands on modern healthcare systems, the industry’s response has vividly demonstrated its resilience and ability to bring innovations to market quickly
AND
Similarly, hospitals are caring for COVID-19 patients with evolving protocols while maintaining continuity of care for others, often against the backdrop of vulnerable staff, supply and equipment shortages, and, for some, accelerating financial headwinds.
NEXT
Waiving IPP would significantly hinder innovation
Mercurio, B., 2021. Bryan Mercurio is the Simon F.S. Li Professor of Law at the Chinese University of Hong Kong (CUHK), having served as Associate Dean (Research) from 2010-14 and again from 2017-19. Professor Mercurio specialises in international economic law (IEL), with particular expertise in the intersection between trade law and intellectual property rights, free trade agreements, trade in services, dispute settlement and increasingly international investment law. WTO Waiver from Intellectual Property Protection for COVID-19 Vaccines and Treatments: A Critical Review. Available at SSRN 3789820. https://poseidon01.ssrn.com/delivery.php?ID=5110221230090210951211210950030061000150850670470490060691160211210170160930010860100590330630050470620230060101221000871
06085038043041039017018067015029074117023058085018068098117003022120122101027083075101030105095090101088081023002003084097112094andEXT=pdfandINDEX=TRUE
The IP system is designed to encourage and reward creativity and innovation while benefiting society as a whole.
AND
It would be unwise (if not reckless) to place the innovation system which has delivered results in record time in jeopardy only in exchange for what is at best short-term benefits.
NEXT
The alternative to a patent system is trade secrecy which chills innovation
John Raidt 14, Vice President, Jones Group International Scholar, U.S. Chamber of Commerce Foundation Senior Fellow, Atlantic Council, "Patents and Biotechnology", US Chamber of Commerce Foundation, https://www.uschamberfoundation.org/patents-and-biotechnology
What would our innovation system look like without patents?
NEXT
Thus, we are all stakeholders in the patent debate and, in particular, the life science patent debate.